GlassScriptPhysician profile
Maryna Popp
NPI 1326486515
$5,750.58
in general payments reported to CMS, 2019-2025
19 companies · $667 in 2025
The $667 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,177 · 2020: $652 · 2021: $95.99 · 2022: $216 · 2023: $332 · 2024: $611 · 2025: $667.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,610.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,610.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $2,740.50 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $791.77 | 2022-2025 | |
| Amgen INC. | $501.18 | 2019-2025 | Repatha, Repatha |
| Astrazeneca Pharmaceuticals LP | $273.08 | 2019-2024 | Wainua, Farxiga, Brilinta |
| Abbott Laboratories | $260.67 | 2019-2024 | Thoratec Heartmate 3 Lvas Implant Kit |
| Medtronic Vascular, INC. | $247.96 | 2019-2020 | |
| Novo Nordisk INC | $184.12 | 2024-2025 | Ozempic, Wegovy, Rybelsus |
| Pfizer INC. | $120.40 | 2019-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $115.88 | 2019-2022 | |
| United Therapeutics Corporation | $82.51 | 2021 | |
| Cardiovascular Systems INC. | $82.25 | 2019-2020 | |
| Cvrx, INC. | $80.32 | 2025 | Barostim Neo System |
| Boston Scientific Corporation | $63.48 | 2023-2024 | Watchman Access System |
| Janssen Pharmaceuticals, INC | $58.27 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $37.04 | 2023-2024 | Camzyos |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scpharmaceuticals INC. | $31.87 | 2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $31.39 | 2024 | Jardiance |
| Lexicon Pharmaceuticals, INC. | $29.05 | 2024 | |
| Medtronic, INC. | $18.84 | 2024 | Linq II |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maryna Popp listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.